Sensus Healthcare Ownership
| SRTS Stock | USD 4.42 0.08 1.84% |
Shares in Circulation | First Issued 2015-03-31 | Previous Quarter 16.4 M | Current Value 16.4 M | Avarage Shares Outstanding 14.9 M | Quarterly Volatility 2 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sensus Healthcare. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. Sensus Stock Ownership Analysis
About 17.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.35. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Sensus Healthcare had not issued any dividends in recent years. Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida. Sensus Healthcare operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 37 people. To find out more about Sensus Healthcare contact Joseph Sardano at 561 922 5808 or learn more at https://sensushealthcare.com.Besides selling stocks to institutional investors, Sensus Healthcare also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Sensus Healthcare's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Sensus Healthcare's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Sensus Healthcare Quarterly Liabilities And Stockholders Equity |
|
Sensus Healthcare Insider Trades History
About 17.0% of Sensus Healthcare are currently held by insiders. Unlike Sensus Healthcare's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Sensus Healthcare's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Sensus Healthcare's insider trades
Sensus Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Sensus Healthcare is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Sensus Healthcare backward and forwards among themselves. Sensus Healthcare's institutional investor refers to the entity that pools money to purchase Sensus Healthcare's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Two Sigma Investments Llc | 2025-03-31 | 89.6 K | Meros Investment Management, Lp | 2025-03-31 | 88.5 K | Ubs Group Ag | 2025-03-31 | 85.6 K | Northern Trust Corp | 2025-03-31 | 84.7 K | Blackrock Inc | 2025-03-31 | 65.8 K | Gsa Capital Partners Llp | 2025-03-31 | 65 K | State Street Corp | 2025-03-31 | 59.9 K | Divisadero Street Capital Management, Lp | 2025-03-31 | 58 K | Squarepoint Ops Llc | 2025-03-31 | 57.5 K | Vanguard Group Inc | 2025-03-31 | 740 K | Dimensional Fund Advisors, Inc. | 2025-03-31 | 541.7 K |
Sensus Healthcare Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Sensus Healthcare insiders, such as employees or executives, is commonly permitted as long as it does not rely on Sensus Healthcare's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Sensus Healthcare insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Sensus Healthcare Outstanding Bonds
Sensus Healthcare issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Sensus Healthcare uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Sensus bonds can be classified according to their maturity, which is the date when Sensus Healthcare has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| SENMED 2927 01 NOV 51 Corp BondUS81728XAA63 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| ST 5875 01 SEP 30 Corp BondUS81725WAL72 | View | |
| US81725WAK99 Corp BondUS81725WAK99 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| SENIOR HSG PPTYS Corp BondUS81721MAM10 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Sensus Stock Analysis
When running Sensus Healthcare's price analysis, check to measure Sensus Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sensus Healthcare is operating at the current time. Most of Sensus Healthcare's value examination focuses on studying past and present price action to predict the probability of Sensus Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sensus Healthcare's price. Additionally, you may evaluate how the addition of Sensus Healthcare to your portfolios can decrease your overall portfolio volatility.